Loading...
Mahkam Zanganeh received $1.2M in total compensation as Co-Chief Executive Officer, President and Director of Summit Therapeutics Inc. in FY2024. The largest component was $600K in base salary. That’s down 94% from FY2023. Source: SEC 20-F.
In fiscal year 2024, Mahkam Zanganeh, Co-Chief Executive Officer, President and Director of Summit Therapeutics Inc. (SMMT), received total compensation of $1.2 million.
Mahkam Zanganeh's compensation breakdown includes: base salary of $600K, bonus of $540K, and other compensation of $21K.
Compared to fiscal year 2023, Mahkam Zanganeh's total compensation decreased 94% from $20.6 million to $1.2 million.
Summit Therapeutics Inc.'s top 4 named executive officers received combined total compensation of $6.3 million in fiscal year 2024.
The named executive officers disclosed in Summit Therapeutics Inc.'s 2024 proxy statement are:Mahkam Zanganeh (Co-Chief Executive Officer, President and Director) with total compensation of $1.2 million, Robert W. Duggan (Chief Executive Officer and Executive Chairman) with total compensation of $159K, Manmeet Soni (Chief Operating Officer, Chief Financial Officer and Director) with total compensation of $4.8 million, and Ankur Dhingra (Former Chief Financial Officer) with total compensation of $256K.
Co-Chief Executive Officer, President and Director
98% cash · 2% other
Based on 20-F filed 2025-04-29 · FY2024
Team view
4 executives
Co-Chief Executive Officer, President and Director
Total PayFY2024
$1.2M
Chief Executive Officer and Executive Chairman
Total PayFY2024
$159K
Chief Operating Officer, Chief Financial Officer and Director
Total PayFY2024
$4.8M
Former Chief Financial Officer
Total PayFY2024
$256K
FY2024 total compensation breakdown
$1.2M total compensation
Mahkam Zanganeh earned $1.2M in FY2024 — here's how that breaks down.
$600.0K
52% of total
$540.0K
47% of total
$21.0K
2% of total
Activity timeline · FY2024
Recent events from filings
Apr 2, 2024
Manmeet Soni Equity award (Exercise $1,100,000)
Jan 2, 2024
Robert W. Duggan Equity award (Exercise $74,545)
An AI summary will appear here once the pay verdict loads above.
Pay changes vs. stock performance
Recent insider trades by officers and directors
103 trades
For analysts and deep research
Historical compensation data from latest proxy filing
| Year | Executive | Salary | Bonus & Incentive | Stock Awards | Option Awards | Other Adj. | Total |
|---|---|---|---|---|---|---|---|
| 2024 | Mahkam Zanganeh Co-Chief Executive Officer, President and Director | $0.60M | $0.54M | $0.00M | $0.00M | $0.02M | $1.16M |
| 2023 | Mahkam Zanganeh Co-Chief Executive Officer, President and Director | $0.60M | $0.00M | $0.00M | $19.9M | $0.06M | $20.6M |
| 2022 | Mahkam Zanganeh Co-Chief Executive Officer, President and Director | $0.45M | $0.45M | $0.00M | $0.31M | $0.03M | $1.24M |
| 2021 | Mahkam Zanganeh Co-Chief Executive Officer, President and Director | $0.45M | $0.18M | $0.00M | $8.99M | $0.02M | $9.64M |
Salary = base cash pay. Bonus & Incentive combines annual bonus and non-equity plans. Equity amounts are grant-date fair values. Other Adj. captures pension changes, perquisites, and any reconciliation items so the total matches the reported figure.
Get one email when new executive compensation data is filed and processed.